1. Home
  2. SLNG vs CUE Comparison

SLNG vs CUE Comparison

Compare SLNG & CUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stabilis Solutions Inc.

SLNG

Stabilis Solutions Inc.

HOLD

Current Price

$5.28

Market Cap

97.4M

Sector

Utilities

ML Signal

HOLD

Logo Cue Biopharma Inc.

CUE

Cue Biopharma Inc.

HOLD

Current Price

$31.79

Market Cap

233.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SLNG
CUE
Founded
2013
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Oil/Gas Transmission
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
97.4M
233.5M
IPO Year
2019
2017

Fundamental Metrics

Financial Performance
Metric
SLNG
CUE
Price
$5.28
$31.79
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$10.00
★ $120.00
AVG Volume (30 Days)
36.1K
★ 345.6K
Earning Date
05-06-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 2400.00
61.11
EPS
★ N/A
N/A
Revenue
★ $68,245,000.00
$27,466,000.00
Revenue This Year
$8.66
N/A
Revenue Next Year
$14.31
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ 195.75
52 Week Low
$3.21
$0.17
52 Week High
$7.07
$45.50

Technical Indicators

Market Signals
Indicator
SLNG
CUE
Relative Strength Index (RSI) 49.10 52.87
Support Level $4.79 $23.47
Resistance Level $5.46 $33.11
Average True Range (ATR) 0.37 4.89
MACD -0.04 0.09
Stochastic Oscillator 31.33 45.37

Price Performance

Historical Comparison
SLNG
CUE

About SLNG Stabilis Solutions Inc.

Stabilis Solutions Inc is an energy transition company that provides turnkey clean energy production, storage, transportation, and fueling solutions using liquefied natural gas (LNG) to multiple end markets. The company provides LNG solutions to customers in diverse end markets, including aerospace, agriculture, energy, industrials, marine bunkering, mining, pipeline, remote power, and utility markets. It generates revenue by selling and delivering LNG to its customers, renting cryogenic equipment, and providing engineering and field support services. The company has a geographical presence in the United States and Mexico.

About CUE Cue Biopharma Inc.

Cue Biopharma Inc is a clinical-stage therapeutics company focused on advancing a robust portfolio of potentially transformative therapies aimed at enabling functional cures across immunological disorders. Its product pipeline includes CUE-221, an anti-IgE antibody candidate being developed for allergic diseases. The company has also developed the Immuno-STAT platform for targeting disease-related T cells and is developing CUE-401, an IL-2 and TGF-B therapeutic candidate for autoimmune diseases.

Share on Social Networks: